Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation

Yoshinori Katsuragi1, Noriyuki Sagata

  • 1Department of Biology, Graduate School of Sciences, Kyushu University, Fukuoka 812-8581, Japan.

Insights

The DNA replication checkpoint kinase Chk1 is activated by ATR-mediated phosphorylation. Researchers found an autoinhibitory region (AIR) in Xenopus Chk1 that is regulated by ATR phosphorylation, revealing a key activation mechanism.

Area of Science:

  • Cellular biology
  • Molecular biology
  • Biochemistry

Background:

  • The checkpoint kinase Chk1 is crucial for the DNA replication checkpoint.
  • ATR-mediated phosphorylation activates Chk1 in response to unreplicated DNA.
  • The exact mechanism of Chk1 activation by ATR is not fully understood.

Purpose of the Study:

  • To investigate the domain structure of Xenopus Chk1.
  • To elucidate the mechanism of Chk1 activation by ATR-mediated phosphorylation.
  • To identify regulatory regions involved in Chk1 activation.

Main Methods:

  • Analysis of Xenopus Chk1 domain structure.
  • Coexpression of Chk1 domains in oocytes and embryos.
  • Site-directed mutagenesis to create phospho-mimic mutations.
  • Assays to detect protein-protein interactions and inhibition.

Main Results:

  • Identified an autoinhibitory region (AIR) in the C-terminus of Xenopus Chk1.
  • AIR overlaps with a long nuclear localization signal and inhibits the Chk1 kinase domain.
  • ATR-mediated phosphorylation or mimic mutations disrupt AIR's inhibitory function, suggesting a conformational change.
  • Autoinhibition can be overcome in full-length Chk1 with specific mutations.

Conclusions:

  • ATR-mediated phosphorylation induces a conformational change in Chk1's AIR, releasing kinase inhibition.
  • This study provides significant insights into the regulation of Chk1 activation during the DNA replication checkpoint.
  • The findings highlight the importance of intramolecular interactions in Chk1 regulation.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...